FIELD: pharmacology.
SUBSTANCE: group of inventions relates to the field of biochemistry and pharmacology, namely to drugs based on peptides that improve the functional properties of the vascular endothelium in their violation of various genesis, including atherosclerosis. The use of the peptide formula β-aspartyl-alanine H-Asp(Ala)-OH is proposed to improve the functional activity of the vascular endothelium, as well as in the prevention and/or treatment of endothelial dysfunction, for example, such as endothelial dysfunction in atherosclerosis, restenosis, coronary heart disease, cerebral circulation disorders.
EFFECT: expansion of the range of medicines based on peptides to improve the functional properties of the vascular endothelium.
3 cl, 2 dwg, 1 tbl, 6 ex
Authors
Dates
2022-03-28—Published
2021-06-30—Filed